TY - JOUR
T1 - Iodine and lithium-induced hypothyroidism. Documentation of synergism
AU - Shopsin, B.
AU - Shenkman, L.
AU - Blum, M.
AU - Hollander, C. S.
N1 - Funding Information:
From the Endocrine Unit, Department Medicine, and the Neuropsychopharmacolo-gy Research Unit, Department of Psychiatry, New York University School of Medicine, New York, New York. This work was supported by U.S. Public Health Service Grant No. MH-1-7436 (B.S.), 1 F03 AM 5156-02 (L.S., M.B., C.S.H.), ROI AM 14314-03 (L.S., M.B., C.S.H.) and FR-96. Requests for reprints should be addressed to Dr. C. S. Hollander, New York University Medical Center, 550 First Avenue, New York, New York 10016. Manuscript accepted July 30, 1973.
PY - 1973/11
Y1 - 1973/11
N2 - Signs and symptoms of hypothyroidism were noted in a patient receiving lithium carbonate for 2 years as prophylaxis against recurrence of mania and depression. When lithium therapy was stopped, the hypothyroidism resolved; but it recurred with the administration of potassium iodide. When potassium iodide therapy was discontinued, the patient became euthyroid. In a second patient chemical evidence of hypothyroidism (fall in circulating thyroid hormone levels, elevation of serum thyrotropin) was noted after he had received 3 weeks of lithium therapy. With the addition of potassium iodide, laboratory evidence of hypothyroidism became more pronounced, and clinical signs of hypothyroidism developed. All abnormalities resolved promptly following the withdrawal of lithium and iodine. These observations suggest that lithium and iodine can act synergistically to produce hypothyroidism and that the combined use of these agents should be avoided.
AB - Signs and symptoms of hypothyroidism were noted in a patient receiving lithium carbonate for 2 years as prophylaxis against recurrence of mania and depression. When lithium therapy was stopped, the hypothyroidism resolved; but it recurred with the administration of potassium iodide. When potassium iodide therapy was discontinued, the patient became euthyroid. In a second patient chemical evidence of hypothyroidism (fall in circulating thyroid hormone levels, elevation of serum thyrotropin) was noted after he had received 3 weeks of lithium therapy. With the addition of potassium iodide, laboratory evidence of hypothyroidism became more pronounced, and clinical signs of hypothyroidism developed. All abnormalities resolved promptly following the withdrawal of lithium and iodine. These observations suggest that lithium and iodine can act synergistically to produce hypothyroidism and that the combined use of these agents should be avoided.
UR - http://www.scopus.com/inward/record.url?scp=0015856853&partnerID=8YFLogxK
U2 - 10.1016/0002-9343(73)90193-9
DO - 10.1016/0002-9343(73)90193-9
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0015856853
VL - 55
SP - 695
EP - 699
JO - American Journal of Medicine
JF - American Journal of Medicine
SN - 0002-9343
IS - 5
ER -